Hokuetsu Corp
OTC:HKPMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hokuetsu Corp
OTC:HKPMF
|
JP |
|
Xinjiang Goldwind Science & Technology Co Ltd
F:CXGH
|
CN |
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
El Puerto de Liverpool SAB de CV
F:PLV1
|
MX |
|
Spinnova Oyj
F:9HP
|
FI |
|
I
|
Innate Pharma SA
XBER:IDD
|
FR |
|
E
|
Ensign Group Inc
F:EGB
|
US |
|
Fuji Kyuko Co Ltd
F:8V7
|
JP |
Wall St Price Targets
HKPMF Price Targets Summary
Hokuetsu Corp
According to Wall Street analysts, the average 1-year price target for HKPMF is 12.95 USD with a low forecast of 12.83 USD and a high forecast of 13.33 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HKPMF's stock price target?
Price Target
12.95
USD
According to Wall Street analysts, the average 1-year price target for HKPMF is 12.95 USD with a low forecast of 12.83 USD and a high forecast of 13.33 USD.
What is the Revenue forecast for Hokuetsu Corp?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Hokuetsu Corp?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 13 years is -4%.
What is the Net Income forecast for Hokuetsu Corp?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is -5%.
